AVR milestones, page-15

As the same comments made in reference to the science, break thru, ect, ect, (since time immemorial) if it is not in the control of the company to sell itself, adequately, then how far away before it can, without a offer in the wings.

What I said about the need to break this cycle with a offer.

The lack of a offer will see this company at the mercy of opportunistic third parties for the foreseeable future, for a company that has a ‘game changer’ of IP it seemingly has no ability to call the shots, not exactly the best position to gain the maximum benefit for RI.

If the hype reflected in the sp, to some extent, it would be grounds for a lot more positivity, until then it should concern RIs that further dilution, at current levels, enables other entities to continue their agendas.

Ultimately out of the control of RIs, how much out of control of the company should be a worry.

My ‘shite’ is only background noise in the grand scheme of things. 2023 needs to see a break thru in the sp to finally reflect the value of the science.

Safe hols and New year to all.